Here are some of the major companies whose stocks moved on the week’s news.

Novo Nordisk (NVO) was slammed by a U.K. trade group for violating voluntary codes and discrediting the pharmaceutical industry over a failure ...

On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Shares of Danish pharmaceutical giant Novo Nordisk surged close to 14% on Friday after the company announced positive results ...

Danish drugmaker Novo Nordisk has traditionally generated its ... Syros Pharma, Tessera, Valo, and Vesalius. Paul Biondi, president of Flagship's Pioneering Medicines unit, said the partnership ...

Novo Nordisk’s weekly injectable drug Wegovy, which can help people lose more than 10% of their body weight, has been cleared for use on the NHS in England by cost-effectiveness agency NICE.

In the Southwest United States, bird migrations are shifting as global temperatures warm. Gustavo Martіnez Contreras takes us to the Bosque del Apache National Wildlife Refuge in the state of New ...

The Bank of Japan raised interest rates to their highest since the 2008 global financial crisis, underscoring its confidence that rising wages will keep inflation stable around its 2% target.